Bharat Biotech top brass calls on Vice President M Venkaiah Naidu to discuss Covaxin status
New Delhi: Bharat Biotech''s top brass on Friday called on Vice President M Venkaiah Naidu in Hyderabad.
"The discussion revolved around the status of the indigenous vaccine and the plans to make it available in India and rest of the world. It is developed by Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR)-National Institute of Virology (NIV)," an official statement said.
The indigenous, inactivated vaccine is being developed and manufactured in Bharat Biotech''s BSL-3 (Bio-Safety Level 3) bio-containment facility, the statement said.
Recently, Prime Minister Narendra Modi had visited Bharat Biotech''s facility and reviewed the status of Covaxin. It was followed by a visit of 70 ambassadors and high commissioners from several nations to the facility at Genome Valley, Hyderabad, it said.
Read also: AIIMS Delhi invites volunteers for Phase 3 Trial Of Bharat Biotech Covaxin
During the interaction, the vice president stressed on the importance of public-private partnership in coming out with indigenous world-class products and lauded the collaboration between the ICMR and Bharat Biotech, it said.
Read also: Bharat Biotech re-applies with DCGI for emergency approval of Covaxin
